CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice

被引:36
作者
Manning, BM
Enioutina, EY
Visic, DM
Knudson, AD
Daynes, RA
机构
[1] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA
[2] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Salt Lake City, UT 84112 USA
关键词
CpG DNA; adjuvant; vaccine; aging; dendritic cell;
D O I
10.1016/S0531-5565(01)00157-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The present studies demonstrate that the immunization of aged mice with Diphtheria toxoid in formulations containing unmethylated immunostimulatory CpG motifs, promotes the successful development of immune responses that are qualitatively and quantitatively comparable to those induced in young animals vaccinated in a similar manner. Aged mice given vaccines containing CpG oligodeoxynucleotides (ODNs) expressed primary and secondary systemic humoral immune responses having isotype profiles consistent with an enhancement in Th-1 type immunity. The ability to generate common mucosal immunity was also restored in aged animals given CpG ODN-containing vaccines. Dendritic cells (DCs) were determined to represent one of the cellular targets of CpG ODN activities in aged mice since restoration of immune function was observed when DCs from aged donors were pulsed with antigen and CpG ODNs, prior to injection into syngeneic young adult or aged recipients. Interestingly, antigen-pulsed DCs from young donors were fully capable of stimulating immune responses following their injection into syngeneic young adult or aged hosts, without a need for exposure to CpG ODNs. Although the mechanism(s) by which CpG DNA exerts its beneficial adjuvant effects on the aged immune system remains unclear, our findings suggest that the incorporation of CpG ODNs into vaccine formulations provided to the aged could prove useful in the development of more effective vaccines for the elderly. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:107 / 126
页数:20
相关论文
共 77 条
  • [1] CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms
    Askew, D
    Chu, RS
    Krieg, AM
    Harding, CV
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (12) : 6889 - 6895
  • [2] Ballas ZK, 1996, J IMMUNOL, V157, P1840
  • [3] BELSITO DV, 1989, J IMMUNOL, V143, P1530
  • [4] Efficacy of anti-influenza peptide vaccine in aged mice
    Ben-Yedidia, T
    Abel, L
    Arnon, R
    Globerson, A
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 104 (01) : 11 - 23
  • [5] Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5+B cells
    Ben-Yehuda, A
    Szabo, P
    LeMaoult, J
    Manavalan, JS
    Weksler, ME
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 103 (02) : 111 - 121
  • [6] Bender BS, 1999, VACCINE, V17, P1581
  • [7] Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice
    Bender, BS
    Ulmer, JB
    DeWitt, CM
    Cottey, R
    Taylor, SF
    Ward, AM
    Friedman, A
    Liu, MA
    Donnelly, JJ
    [J]. VACCINE, 1998, 16 (18) : 1748 - 1755
  • [8] Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
    Chace, JH
    Hooker, NA
    Mildenstein, KL
    Krieg, AM
    Cowdery, JS
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (02): : 185 - 193
  • [9] IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
    Chomarat, P
    Banchereau, J
    Davoust, J
    Palucka, AK
    [J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 510 - 514
  • [10] Adjuvants - A classification and review of their modes of action
    Cox, JC
    Coulter, AR
    [J]. VACCINE, 1997, 15 (03) : 248 - 256